Resources

GPs should take seriously the threat of whistleblower action on any questionable practices, writes Phillips & Cohen partner Stephen Hasegawa in “Private Funds Management.” PUBLISHED: 06...

WASHINGTON, DC – The Internal Revenue Service has made a whistleblower reward to a client of Phillips & Cohen totaling nearly $20 million for whistleblower claims that exposed a number of abusive...

WASHINGTON, DC – A whistleblower lawsuit, brought by Phillips & Cohen, has exposed an illegal scheme where doctors have purchased illegally imported cancer drugs as a way to cut their costs and...

Gabelli, affiliates settle fraud suit for $130 million By Paul Davies The Wall Street Journal, July 14, 2006 NEW YORK — Money manager Mario Gabelli and his affiliated companies agreed to pay $130...

By Erika Kelton Phillips & Cohen LLP Washington, DC Note: An edited version of this article appeared in the March 20, 2006 issue of Drug Topics under the title, “Qui tam suits and you.”...

TAP Pharmaceutical whistleblower Joseph Gerstein alleged in a qui tam whistleblower complaint that TAP was paying illegal kickbacks to doctors who dispensed the company’s high priced prostate cancer...

WASHINGTON, DC – The proposed Columbia/HCA Healthcare Corp. settlement announced yesterday is only the first step in resolving a series of whistleblower lawsuits, brought by Phillips & Cohen,...

Is it Medicare fraud when a healthcare provider fails to report Medicare billing errors? In many hospitals and other healthcare institutions there is a tendency to think that nothing needs to be done when...